The goal of the new white paper is to create a dramatic shift in how lupus clinical trials are conducted so effective treatments can stand a chance to succeed.
The project is focused on lupus, which affects up to 1.5 million Americans.
As a scientist, I am often asked this question. I always answer this with one word: yes.
OMRF, Stephenson Cancer Center begin tests of experimental compound
Breakthroughs in MS research will bring a wave of new medications to market.